Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,144,662
+$10,075,302 QoQ
Shares Held
97,189
+657.0% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#74
of 273 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. KYMR ranks #31 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in KYMR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,144,662 | 97,189 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,069,360 | 12,839 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,404,937 | 159,426 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $19,880,523 | 351,246 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,454,259 | 33,324 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $1,346,302 | 49,189 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $1,946,086 | 48,374 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,479,938 | 73,525 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,240,605 | 108,563 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,427,090 | 85,251 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $717,921 | 28,198 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $422,393 | 30,388 | Shares | Defined | 2023-11-14 | |
| 2022-12-31 | $546,074 | 21,878 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,588,039 | 118,881 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,561,968 | 79,328 | Shares | Defined | 2022-08-15 | |
| 2021-09-30 | $851,671 | 14,499 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,367,527 | 48,815 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $560,011 | 14,411 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $292,243 | 9,045 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||